Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

EMRELIS vs MVASI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. EMRELIS and MVASI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

emrelismvasi

Rating

72/100
72/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

TELISOTUZUMAB VEDOTIN-TLLV
BEVACIZUMAB-AWWB

Manufacturer

Abbvie
Amgen Inc

Dosage forms

Injectable
Injectable

Drug class

—
—

Boxed warning

None
None

Treats

Non-Small-Cell Lung Carcinoma
Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Frequently asked questions

Which is better-rated, Emrelis or Mvasi?

Emrelis and Mvasi are tied at 3.6 out of 5 by our independent rating.

What is the difference between Emrelis and Mvasi?

Emrelis contains Telisotuzumab Vedotin-Tllv, while Mvasi contains Bevacizumab-Awwb — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.